These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3013569)

  • 1. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
    Hemsell DL
    Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease.
    Gunning J
    Drugs; 1986; 31 Suppl 2():14-7. PubMed ID: 3013567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections.
    Crombleholme W; Landers D; Ohm-Smith M; Robbie MO; Hadley WK; DeKay V; Dahrouge D; Sweet RL
    Drugs; 1986; 31 Suppl 2():11-3. PubMed ID: 3013566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
    Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
    Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
    Crombleholme WR; Ohm-Smith M; Robbie MO; DeKay V; Sweet RL
    Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
    Senft HH; Stiglmayer R; Eibach HW; Koerner H
    Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
    Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
    J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV; Reines HD; Hunt P
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease.
    Sweet RL; Landers DV; Schachter J; Crombleholme WR
    Suppl Int J Gynecol Obstet; 1989; 2():13-9; discussion 47-8. PubMed ID: 2803578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
    Wexler HM; Harris B; Carter WT; Finegold SM
    Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections.
    Reinhardt JF; Johnston L; Ruane P; Johnson CC; Ingram-drake L; MacDonald K; Ward KW; Mathisen G; George WL; Finegold SM
    Rev Infect Dis; 1986; 8 Suppl 5():S569-75. PubMed ID: 3026005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
    McGregor JA; Crombleholme WR; Newton E; Sweet RL; Tuomala R; Gibbs RS
    Obstet Gynecol; 1994 Jun; 83(6):998-1004. PubMed ID: 8190448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D; Esposito S; Barba D; Ruffilli MP
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
    Wald E; Reilly JS; Bluestone CD; Chiponis D
    Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
    Plouffe JF
    Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparative study of sulbactam plus ampicillin vs. metronidazole plus cefotaxime in the management of acute appendicitis in children.
    Foster MC; Kapila L; Morris DL; Slack RC
    Rev Infect Dis; 1986; 8 Suppl 5():S634-8. PubMed ID: 3026017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
    Lees L; Milson JA; Knirsch AK; Greenhalgh K
    Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.